Quantum BioPharma Statistics

Total Valuation

Quantum BioPharma has a market cap or net worth of CAD 8.08 million. The enterprise value is -1.61 million.

Market Cap	8.08M
Enterprise Value	-1.61M

Important Dates

The next estimated earnings date is Friday, March 7, 2025.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Quantum BioPharma has 1.92 million shares outstanding. The number of shares has increased by 31.09% in one year.

Current Share Class	n/a
Shares Outstanding	1.92M
Shares Change (YoY)	+31.09%
Shares Change (QoQ)	+43.15%
Owned by Insiders (%)	16.90%
Owned by Institutions (%)	2.80%
Float	1.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.36
P/TBV Ratio	0.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.12
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.02.

Current Ratio	3.76
Quick Ratio	3.72
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-367.85

Financial Efficiency

Return on equity (ROE) is -73.84% and return on invested capital (ROIC) is -46.47%.

Return on Equity (ROE)	-73.84%
Return on Assets (ROA)	-37.73%
Return on Capital (ROIC)	-46.47%
Revenue Per Employee	n/a
Profits Per Employee	-813,509
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -93.44% in the last 52 weeks. The beta is 0.82, so Quantum BioPharma's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	-93.44%
50-Day Moving Average	6.85
200-Day Moving Average	20.03
Relative Strength Index (RSI)	28.71
Average Volume (20 Days)	4,711

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.48M
Pretax Income	-15.01M
Net Income	-13.83M
EBITDA	-14.81M
EBIT	-15.48M
Earnings Per Share (EPS)	-17.44

Full Income Statement

Balance Sheet

The company has 8.92 million in cash and 503,937 in debt, giving a net cash position of 8.42 million or 4.39 per share.

Cash & Cash Equivalents	8.92M
Total Debt	503,937
Net Cash	8.42M
Net Cash Per Share	4.39
Equity (Book Value)	20.73M
Book Value Per Share	11.81
Working Capital	13.73M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-9.31M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Quantum BioPharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.09%
Shareholder Yield	-31.09%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on August 15, 2024. It was a reverse split with a ratio of 0.0153846154.

Last Split Date	Aug 15, 2024
Split Type	Reverse
Split Ratio	0.0153846154

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a